Search research articles
Contact Us
Filters
Showing results (231-240 of 274) with videos related to
Page
of 28
Sort By:
The Journal of Infectious Diseases
|
April 29, 2017
Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses
Anindya Siddharta, Stephanie Pfaender, Nathalie Jane Vielle, et al.
Iscience
|
August 16, 2024
Dissecting humoral immune responses to an MVA-vectored MERS-CoV vaccine in humans using a systems serology approach
Leonie M Weskamm, Paulina Tarnow, Charlotte Harms, et al.
Nature Communications
|
January 9, 2026
Two-year persistence of MERS-CoV-specific antibody and T cell responses after MVA-MERS-S vaccination in healthy adults
Leonie Mayer, Anahita Fathi, Hanna-Marie Weichel, et al.
The Journal of Infectious Diseases
|
November 20, 2018
Detectable Vesicular Stomatitis Virus (VSV)-Specific Humoral and Cellular Immune Responses Following VSV-Ebola Virus Vaccination in Humans
Joseph H Poetsch, Christine Dahlke, Madeleine E Zinser, et al.
Immunity
|
November 13, 2012
Nucleic acid-sensing Toll-like receptors are essential for the control of endogenous retrovirus viremia and ERV-induced tumors
Philipp Yu, Wolger Lübben, Heike Slomka, et al.
Antiviral Research
|
February 12, 2018
The molecular tweezer CLR01 inhibits Ebola and Zika virus infection
Annika E Röcker, Janis A Müller, Erik Dietzel, et al.
The Lancet. Infectious Diseases
|
August 8, 2015
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
Angela Huttner, Julie-Anne Dayer, Sabine Yerly, et al.
Plos One
|
November 21, 2017
Spectrum of pathogen- and model-specific histopathologies in mouse models of acute pneumonia
Kristina Dietert, Birgitt Gutbier, Sandra M Wienhold, et al.
Ebiomedicine
|
April 25, 2017
Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization
Christine Dahlke, Rahel Kasonta, Sebastian Lunemann, et al.
The Journal of Allergy and Clinical Immunology
|
August 17, 2018
Development and characterization of DNAzyme candidates demonstrating significant efficiency against human rhinoviruses
Daniel P Potaczek, Sebastian D Unger, Nan Zhang, et al.
Page
of 28
Search research articles
Search
Showing results (231-240 of 274) with videos related to
Sort By:
Page
of 28
The Journal of Infectious Diseases
|
April 29, 2017
Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses
Anindya Siddharta, Stephanie Pfaender, Nathalie Jane Vielle, et al.
Iscience
|
August 16, 2024
Dissecting humoral immune responses to an MVA-vectored MERS-CoV vaccine in humans using a systems serology approach
Leonie M Weskamm, Paulina Tarnow, Charlotte Harms, et al.
Nature Communications
|
January 9, 2026
Two-year persistence of MERS-CoV-specific antibody and T cell responses after MVA-MERS-S vaccination in healthy adults
Leonie Mayer, Anahita Fathi, Hanna-Marie Weichel, et al.
The Journal of Infectious Diseases
|
November 20, 2018
Detectable Vesicular Stomatitis Virus (VSV)-Specific Humoral and Cellular Immune Responses Following VSV-Ebola Virus Vaccination in Humans
Joseph H Poetsch, Christine Dahlke, Madeleine E Zinser, et al.
Immunity
|
November 13, 2012
Nucleic acid-sensing Toll-like receptors are essential for the control of endogenous retrovirus viremia and ERV-induced tumors
Philipp Yu, Wolger Lübben, Heike Slomka, et al.
Antiviral Research
|
February 12, 2018
The molecular tweezer CLR01 inhibits Ebola and Zika virus infection
Annika E Röcker, Janis A Müller, Erik Dietzel, et al.
The Lancet. Infectious Diseases
|
August 8, 2015
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
Angela Huttner, Julie-Anne Dayer, Sabine Yerly, et al.
Plos One
|
November 21, 2017
Spectrum of pathogen- and model-specific histopathologies in mouse models of acute pneumonia
Kristina Dietert, Birgitt Gutbier, Sandra M Wienhold, et al.
Ebiomedicine
|
April 25, 2017
Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization
Christine Dahlke, Rahel Kasonta, Sebastian Lunemann, et al.
The Journal of Allergy and Clinical Immunology
|
August 17, 2018
Development and characterization of DNAzyme candidates demonstrating significant efficiency against human rhinoviruses
Daniel P Potaczek, Sebastian D Unger, Nan Zhang, et al.
Page
of 28